Publications

Breast cancer research and treatment

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.

01-11-2011

Human molecular genetics

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

15-08-2011

Annals of oncology : official journal of the European Society for Medical Oncology

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.

01-07-2011

Journal of the National Cancer Institute

Independent prognostic value of screen detection in invasive breast cancer.

06-04-2011

Annals of oncology : official journal of the European Society for Medical Oncology

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

01-04-2010

Nederlands tijdschrift voor geneeskunde

[Secondary use of human tissue: consent and better information required].

07-01-2010

Breast cancer research : BCR

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.

22-12-2009

British journal of cancer

A trial of consent procedures for future research with clinically derived biological samples.

03-11-2009

The Lancet. Oncology

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.

01-11-2009

European journal of cancer (Oxford, England : 1990)

Regulatory aspects of genetic research with residual human tissue: effective and efficient data coding.

01-09-2009

Breast cancer research and treatment

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.

01-07-2009

European journal of cancer (Oxford, England : 1990)

Obtaining 'fresh' consent for genetic research with biological samples archived 10 years ago.

01-05-2009

Journal of clinical pathology

Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment.

01-03-2009

Breast cancer research and treatment

The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

01-01-2008

Cancer research

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

01-10-2007

Breast cancer research : BCR

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

13-04-2007

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

01-01-2007

European journal of human genetics : EJHG

The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.

01-01-2007

EMBO reports

Ablation of the spindle assembly checkpoint by a compound targeting Mps1.

01-09-2005

Nederlands tijdschrift voor geneeskunde

[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy].

20-03-2004

Molecular and cellular biology

Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

01-11-2002

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.

Independent prognostic value of screen detection in invasive breast cancer.

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

[Secondary use of human tissue: consent and better information required].

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.

A trial of consent procedures for future research with clinically derived biological samples.

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.

Regulatory aspects of genetic research with residual human tissue: effective and efficient data coding.

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.

Obtaining 'fresh' consent for genetic research with biological samples archived 10 years ago.

Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment.

The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.

Ablation of the spindle assembly checkpoint by a compound targeting Mps1.

[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy].

Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

This site uses cookies